D-optimal design-based optimization of Etoricoxib cubogel for management of arthritis; In vitro and in vivo Evaluation
{{output}}
Etoricoxib (Et) is selective COX-2 inhibitor with several drawbacks after oral administration. Current study focused on formulating targeted Et cubogel for management of osteoarthritis. Interaction between formulation factors; (glyceryl-monooleate (GMO) and Po... ...
